Glenmark Pharmaceuticals gets FDA approval for generic Protopic Ointment
Glenmark Pharmaceuticals Ltd., a global leader in pharmaceutical research, has secured the final nod from the U.S. Food & Drug Administration (U.S. FDA) for its Tacrolimus Ointment, 0.03%. This ointment stands as the generic counterpart to Leo Pharma AS’s Protopic Ointment, 0.03%. Marking its entry into the U.S. market, the product will be distributed by […]